Impressive response to nivolumab in renal clear cell carcinoma skin metastasis

Ital J Dermatol Venerol. 2022 Aug;157(4):380-382. doi: 10.23736/S2784-8671.22.07151-1. Epub 2022 Mar 11.

Authors

Mario Vaccaro¹, Alfonso Motolese², Federica Li Pomi², Giuseppe Pettineo³, Francesco Borgia²

Affiliations

¹ Section of Dermatology, Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy - mario.vaccaro@unime.it.
² Section of Dermatology, Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy.
³ Medical Oncology Unit, G. Barresi Department of Human Pathology, University of Messina, Messina, Italy.

PMID: 35274877
DOI: 10.23736/S2784-8671.22.07151-1

No abstract available

MeSH terms

Carcinoma, Renal Cell* / drug therapy
Humans
Kidney Neoplasms* / drug therapy
Nivolumab / therapeutic use
Skin Neoplasms* / drug therapy

Substances

Nivolumab